New Directions for Chemotherapy in Non-Small-Cell Lung Cancer
- 1 April 1993
- Vol. 103 (4) , 370S-372S
- https://doi.org/10.1378/chest.103.4_supplement.370s
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Camptothecins.Journal of Clinical Oncology, 1992
- A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- Fotemustine: French multicenter phase II study in 67 patients with advanced non small cell lung carcinoma (NSCLC)Lung Cancer, 1991
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- A late phase II study of navelbine (vinorelbine), a new vinca alkaloid derivative, in non small cell lung cancerLung Cancer, 1991
- Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancerInvestigational New Drugs, 1990
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.Journal of Clinical Oncology, 1988
- New agents in non-small cell lung cancerCancer Treatment Reviews, 1984